Effect of ranolazine on atrial fibrillation in patients with non-ST elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial. [electronic resource]
Producer: 20150908Description: 32-7 p. digitalISSN:- 1532-2092
- Acetanilides -- administration & dosage
- Acute Coronary Syndrome -- drug therapy
- Age Distribution
- Aged
- Aged, 80 and over
- Atrial Fibrillation -- drug therapy
- Comorbidity
- Drug Administration Schedule
- Female
- Humans
- Longitudinal Studies
- Male
- Massachusetts -- epidemiology
- Piperazines -- administration & dosage
- Placebo Effect
- Prevalence
- Ranolazine
- Risk Factors
- Sodium Channel Blockers -- administration & dosage
- Survival Rate
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.